FDA Approved: DAPTOMYCIN — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for daptomycin filed by Sagent Pharmaceuticals (ANDA 207104), resulting in an approved regulatory action for this pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections
• Right-sided Infective Endocarditis
• Staphylococcus Aureus Bacteremia

Drugs mentioned

• Daptomycin (daptomycin)

Snippet

SUPPL AP for DAPTOMYCIN (DAPTOMYCIN)